|
|
 Previous Article | Table of Contents | Next Article 
Downregulation of the Proinflammatory Cytokine Response to Endotoxin by Pretreatment With the Nontoxic Lipid A Analog SDZ MRL 953 in Cancer Patients
Alexander Kiani,
Astrid Tschiersch,
Elke Gaboriau,
Florian Otto,
Alexander Seiz,
Hans-Peter Knopf,
Peter Stütz,
Lothar Färber,
Ulrike Haus,
Chris Galanos,
Roland Mertelsmann, and
Rupert Engelhardt
From the Division of Hematology/Oncology, Department of Internal Medicine I, University Hospital of Freiburg, Freiburg, Germany; the Sandoz Research Institute, Vienna, Austria; Sandoz Pharma Ltd, Nuremberg, Germany; and the Max Planck Institute for Immunobiology, Freiburg, Germany.
Interfering with the endotoxin-mediated cytokine cascade is thought to be a promising approach to prevent septic complications in gram-negative infections. The synthetic lipid A analog SDZ MRL 953 has been shown to be protective against endotoxic shock and bacterial infection in preclinical in vivo models. As part of a trial of unspecific immunostimulation in cancer patients, we conducted a double-blind, randomized, vehicle-controlled phase I trial of SDZ MRL 953 to investigate, first, its biologic effects and safety of administration in humans and, second, its influence on reactions to a subsequent challenge of endotoxin (Salmonella abortus equi). Twenty patients were treated intravenously with escalating doses of SDZ MRL 953 or vehicle control, followed by an intravenous application of endotoxin (2 ng/kg of body weight [BW]). Administration of SDZ MRL 953 was safe and well-tolerated. SDZ MRL 953 itself increased granulocyte counts and serum levels of granulocyte colony-stimulating factor (G-CSF ) and interleukin-6 (IL-6), but not of the proinflammatory cytokines tumor necrosis factor- (TNF-), IL-1 , and IL-8. Compared with vehicle control, pretreatment with SDZ MRL 953 markedly reduced the release of TNF-, IL-1, IL-8, IL-6, and G-CSF, but augmented the increase in granulocyte counts to endotoxin. Induction of tolerance to the endotoxin-mediated cascade of proinflammatory cytokines by pretreatment with SDZ MRL 953 in patients at risk may help to prevent complications of gram-negative sepsis.
Blood, Vol. 90 No. 4 (August 15), 1997:
pp. 1673-1683
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. D. Cravens, M. W. Melkus, A. Padgett-Thomas, M. Islas-Ohlmayer, M. del P. Martin, and J. V. Garcia
Development and Activation of Human Dendritic Cells In Vivo in a Xenograft Model of Human Hematopoiesis
Stem Cells,
February 1, 2005;
23(2):
264 - 278.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Deiters, M. Gumenscheimer, C. Galanos, and P. F. Muhlradt
Toll-Like Receptor 2- and 6-Mediated Stimulation by Macrophage-Activating Lipopeptide 2 Induces Lipopolysaccharide (LPS) Cross Tolerance in Mice, Which Results in Protection from Tumor Necrosis Factor Alpha but in Only Partial Protection from Lethal LPS Doses
Infect. Immun.,
August 1, 2003;
71(8):
4456 - 4462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Cross
Invited review: Endotoxin tolerance -- current concepts in historical perspective
Innate Immunity,
April 1, 2002;
8(2):
83 - 98.
[PDF]
|
|
|
|
|
|
|
M. D. Lehner, J. Ittner, D. S. Bundschuh, N. van Rooijen, A. Wendel, and T. Hartung
Improved Innate Immunity of Endotoxin-Tolerant Mice Increases Resistance to Salmonella enterica Serovar Typhimurium Infection despite Attenuated Cytokine Response
Infect. Immun.,
January 1, 2001;
69(1):
463 - 471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Rayhane, C. Fitting, and J.-M. Cavaillon
Dissociation of IFN-{gamma} from IL-12 and IL-18 production during endotoxin tolerance
Innate Immunity,
October 1, 1999;
5(5-6):
319 - 324.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Kanangat, G. U. Meduri, E. A. Tolley, D. R. Patterson, C. U. Meduri, C. Pak, J. P. Griffin, M. S. Bronze, and D. R. Schaberg
Effects of Cytokines and Endotoxin on the Intracellular Growth of Bacteria
Infect. Immun.,
June 1, 1999;
67(6):
2834 - 2840.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
